Pancreatic Cancer Research

ResearcherShandong UniversityActive in the last 2 years

Chuanxin Wang

Matched on ORCID iD 0000-0001-5234-8752; OpenAlex author ID A5048750980, A5111875004. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 7)
Trials
0
Grants
0
Labs led
1
Collaborators
20
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: 3 papers · 2024: none · 2025: none · 2026: 1 paper

Papers 9

  1. HNRNPC lactylation promotes pancreatic cancer progression through mediating the alternative splicing of PAK6. Co-author DOI 10.1016/j.canlet.2025.218230↗
  2. m6A methylation regulates hypoxia-induced pancreatic cancer glycolytic metabolism through ALKBH5-HDAC4-HIF1α positive feedback loop. Last author DOI 10.1038/s41388-023-02704-8↗
  3. DDX18 drives tumor immune escape through transcription-activated STAT1 expression in pancreatic cancer. Last author DOI 10.1038/s41388-023-02817-0↗
  4. Chromatin accessibility uncovers KRAS-driven FOSL2 promoting pancreatic ductal adenocarcinoma progression through up-regulation of CCL28. Last author DOI 10.1038/s41416-023-02313-y↗
  5. Highly Sensitive Exosome Detection for Early Diagnosis of Pancreatic Cancer Using Immunoassay Based on Hierarchical Surface-Enhanced Raman Scattering Substrate. Last author DOI 10.1002/smtd.202200154↗
  6. The Function of cGAS-STING Pathway in Treatment of Pancreatic Cancer. Last author DOI 10.3389/fimmu.2021.781032↗
  7. Differences between KC and KPC pancreatic ductal adenocarcinoma mice models, in terms of their modeling biology and their clinical relevance. Last author DOI 10.1016/j.pan.2019.11.006↗
  8. The involvement of exosomes in the diagnosis and treatment of pancreatic cancer. Last author DOI 10.1186/s12943-020-01245-y↗
  9. Homoharringtonine could induce quick protein synthesis of PSMD11 through activating MEK1/ERK1/2 signaling pathway in pancreatic cancer cells. Co-author DOI 10.1002/jcb.26847↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yunshan Wang · 4 shared papers, 2020–2022 · strength 0.54
  2. Hanxiang Zhan · 2 shared papers, 2023–2026 · strength 0.44
  3. Abakundana Nsenga Ariston Gabriel · 3 shared papers, 2020–2021 · strength 0.39
  4. Shujun Zhang · 2 shared papers, 2023 · strength 0.35
  5. Guoying Dong · 2 shared papers, 2023 · strength 0.35
  6. J J Li · 2 shared papers, 2022–2023 · strength 0.31
  7. BoHao Li · 1 shared paper, 2026 · strength 0.28
  8. Yangmiao Duan · 1 shared paper, 2026 · strength 0.28
  9. Xiaodong Hao · 1 shared paper, 2023 · strength 0.19
  10. Maoxiao Feng · 1 shared paper, 2023 · strength 0.19
  11. Xiaoyan Liu · 1 shared paper, 2023 · strength 0.19
  12. Wei Gao · 1 shared paper, 2023 · strength 0.18
  13. Huaizhi Wang · 1 shared paper, 2023 · strength 0.18
  14. Jie Gao · 1 shared paper, 2023 · strength 0.16
  15. Xiaoyan Liu · 1 shared paper, 2023 · strength 0.16
  16. Ghazal Mohseni · 1 shared paper, 2021 · strength 0.16
  17. Juan Li · 1 shared paper, 2021 · strength 0.16
  18. Fang Wang · 1 shared paper, 2020 · strength 0.11
  19. Tonggang Qi · 1 shared paper, 2018 · strength 0.09
  20. Dieter Saur · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.